Home › Acute Lymphoblastic Leukemia › Tennessee › Memphis
Acute Lymphoblastic Leukemia clinical trials in Memphis, TN
16 studies for Acute Lymphoblastic Leukemia are looking for participants at sites in and around Memphis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors
RecruitingHealthy volunteers welcome
- St. Jude Children's Research Hospital, Memphis
Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia
RecruitingPhase 1
- St. Jude Children's Research Hospital, Memphis
CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma
RecruitingPhase 1
- St. Jude Children's Research Hospital, Memphis
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RecruitingPhase 1/2
- Saint Jude Children's Research Hospital, Memphis
Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia
Recruiting
- St. Jude Children's Research Hospital, Memphis
Assessment of Remote Approaches for Identification of Autonomic Dysfunction Among Survivors of Leukemia and Lymphoma
Recruiting
- St. Jude Children's Research Hospital, Memphis
Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma
RecruitingPhase 2
- St. Jude Children's Research Hospital, Memphis
Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
RecruitingPhase 4
- St. Jude Children's Research Hospital, Memphis
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecruitingObservational study
- St. Jude Childrens Research Hospital, Memphis
Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity
RecruitingPhase 2
- St. Jude Children's Research Hospital, Memphis
Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase
RecruitingPhase 1/2
- St. Jude Children's Research Hospital, Memphis
CD19-CD22-Bispecific Chimeric Antigen Receptor (CAR) T Cell Therapy for Pediatric Patients With Acute Lymphoblastic Leukemia
RecruitingPhase 1
- St. Jude Children's Research Hospital, Memphis
CAR T CELL Therapy for Pediatric, Adolescent and Young Adult Patients With CD19-Positive Leukemia
RecruitingPhase 2
- St. Jude Children's Research Hospital, Memphis
CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies
RecruitingPhase 1
- St. Jude Children's Research Hospital, Memphis
Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors
RecruitingPhase 2
- St. Jude Children's Research Hospital, Memphis
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
RecruitingPhase 1
- St. Jude Children's Research Hospital, Memphis
Acute Lymphoblastic Leukemia trials in other cities
- Houston, TX28 studies
- New York City, NY24 studies
- Seattle, WA21 studies
- Baldwin Park, CA21 studies
- Chicago, IL19 studies
- Atlanta, GA18 studies
- Washington, DC16 studies
- Philadelphia, PA16 studies
- Boston, MA15 studies
- Los Angeles, CA14 studies
- Mountain View, CA13 studies
- Durham, NC13 studies
Other studies in Memphis
- Cancer (all types)31 studies
- Non-Small Cell Lung Cancer23 studies
- Breast Cancer21 studies
- Sickle Cell Disease18 studies
- Lung Cancer18 studies
- Acute Myeloid Leukemia15 studies
- Heart Failure13 studies
- Colorectal Cancer11 studies
- Prostate Cancer11 studies
- Melanoma11 studies
- Soft Tissue Sarcoma11 studies
- Obesity10 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.